Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Otsuka, Taiga; Shirakawa, Tsuyoshi; Shimokawa, Mototsugu; Koga, Futa; Kawaguchi, Yasunori; Ueda, Yujiro; Nakazawa, Junichi; Komori, Azusa; Otsu, Satoshi; Arima, Shiho; Fukahori, Masaru; Okabe, Yoshinobu; Makiyama, Akitaka; Taguchi, Hiroki; Honda, Takuya; Shibuki, Taro; Nio, Kenta; Ide, Yasushi; Mizuta, Toshihiko; Mitsugi, Kenji; Ureshino, Norio

doi:10.1007/s10147-021-01880-5

Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Correction
Published: 03 March 2021

Volume 26, pages 951–953, (2021)
Cite this article

Download PDF

International Journal of Clinical Oncology Aims and scope Submit manuscript

Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Download PDF

Taiga Otsuka^1,2,
Tsuyoshi Shirakawa ORCID: orcid.org/0000-0002-9317-8216^3,4,
Mototsugu Shimokawa^5,6,
Futa Koga⁷,
Yasunori Kawaguchi^7,8,
Yujiro Ueda⁹,
Junichi Nakazawa¹⁰,
Azusa Komori¹¹,
Satoshi Otsu¹¹,
Shiho Arima¹²,
Masaru Fukahori¹³,
Yoshinobu Okabe¹³,
Akitaka Makiyama^14,15,
Hiroki Taguchi^16,17,
Takuya Honda¹⁸,
Taro Shibuki^19,20,
Kenta Nio²¹,
Yasushi Ide²²,
Toshihiko Mizuta^19,23,
Kenji Mitsugi²⁴ &
…
Norio Ureshino^1,25

1120 Accesses
1 Altmetric
Explore all metrics

The Original Article was published on 23 January 2021

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: International Journal of Clinical Oncology https://doi.org/10.1007/s10147-021-01859-2

In the original publication, Fig. 3 has been published incorrectly. The correct version of Fig. 3 is given in this Correction.

Author information

Authors and Affiliations

Department of Medical Oncology, Saga Medical Center Koseikan, 400 Kase-machi, Saga-shi, Saga, 840-8571, Japan
Taiga Otsuka & Norio Ureshino
Department of Internal Medicine, Minato Medical Clinic, 3-11-3 Nagahama, Chuo-ku, Fukuoka-shi, Fukuoka, 810-0072, Japan
Taiga Otsuka
Department of Medical Oncology, Fukuoka Wajiro Hospital, 2-2-75 Wajirogaoka, Higashi-ku, Fukuoka-shi, Fukuoka, 811-0213, Japan
Tsuyoshi Shirakawa
Karatsu Higashi-Matsuura Medical Association Center, 2566-11 Chiyoda-machi, Karatsu-shi, Saga, 847-0041, Japan
Tsuyoshi Shirakawa
Clinical Research Institute, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka-shi, Fukuoka, 811-1395, Japan
Mototsugu Shimokawa
Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube-shi, Yamaguchi, 755-8505, Japan
Mototsugu Shimokawa
Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, 400 Kase-machi, Saga-shi, Saga, 840-8571, Japan
Futa Koga & Yasunori Kawaguchi
Department of Gastroenterology, Asakura Medical Association Hospital, 422-1 Raiha, Asakura-shi, Fukuoka, 838-0069, Japan
Yasunori Kawaguchi
Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, 2-1-1 Nagamine Minami, Higashi-ku, Kumamoto-shi, Kumamoto, 861-8520, Japan
Yujiro Ueda
Department of Medical Oncology, Kagoshima City Hospital, 37-1 Uearata-cho, Kagoshima-shi, Kagoshima, 890-8760, Japan
Junichi Nakazawa
Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan
Azusa Komori & Satoshi Otsu
Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima, 890-8520, Japan
Shiho Arima
Department of Internal Medicine, Division of Gastroenterology, Kurume University Hospital, 67 Asahi-machi, Kurume-shi, Fukuoka, 830-0011, Japan
Masaru Fukahori & Yoshinobu Okabe
Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-ku, Kitakyushu-shi, Fukuoka, 806-8501, Japan
Akitaka Makiyama
Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu-shi, Gifu, 501-1194, Japan
Akitaka Makiyama
Department of Gastroenterology, Saiseikai Sendai Hospital, 2-46 Harada-cho, Satsumasendai-shi, Kagoshima, 895-0074, Japan
Hiroki Taguchi
Department of Gastroenterology, Izumi General Medical Center, 520 Myojin-cho, Izumi-shi, Kagoshima, 899-0131, Japan
Hiroki Taguchi
Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8501, Japan
Takuya Honda
Department of Internal Medicine, Imari Arita Kyoritsu Hospital, Saga, 860 Ninose-ko, Arita-cho, Nishi-matsuura-gun, Saga, 849-4193, Japan
Taro Shibuki & Toshihiko Mizuta
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan
Taro Shibuki
Department of Medical Oncology, Sasebo Kyosai Hospital, 10-17 Shimanji-cho, Sasebo-shi, Nagasaki, 857-8575, Japan
Kenta Nio
Department of Internal Medicine, Karatsu Red Cross Hospital, 2430 Watada, Karatsu-shi, Saga, 847-8588, Japan
Yasushi Ide
Department of Internal Medicine, Fujikawa Hospital, 1-2-6 Matsubara, Saga-shi, Saga, 840-0831, Japan
Toshihiko Mizuta
Department of Medical Oncology, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-ku, Fukuoka-shi, Fukuoka, 810-8539, Japan
Kenji Mitsugi
Department of Medical Oncology, Kimitsu Chuo Hospital, 1010 Sakurai, Kisarazu-shi, Chiba, 292-8535, Japan
Norio Ureshino

Authors

Taiga Otsuka
View author publications
You can also search for this author in PubMed Google Scholar
Tsuyoshi Shirakawa
View author publications
You can also search for this author in PubMed Google Scholar
Mototsugu Shimokawa
View author publications
You can also search for this author in PubMed Google Scholar
Futa Koga
View author publications
You can also search for this author in PubMed Google Scholar
Yasunori Kawaguchi
View author publications
You can also search for this author in PubMed Google Scholar
Yujiro Ueda
View author publications
You can also search for this author in PubMed Google Scholar
Junichi Nakazawa
View author publications
You can also search for this author in PubMed Google Scholar
Azusa Komori
View author publications
You can also search for this author in PubMed Google Scholar
Satoshi Otsu
View author publications
You can also search for this author in PubMed Google Scholar
Shiho Arima
View author publications
You can also search for this author in PubMed Google Scholar
Masaru Fukahori
View author publications
You can also search for this author in PubMed Google Scholar
Yoshinobu Okabe
View author publications
You can also search for this author in PubMed Google Scholar
Akitaka Makiyama
View author publications
You can also search for this author in PubMed Google Scholar
Hiroki Taguchi
View author publications
You can also search for this author in PubMed Google Scholar
Takuya Honda
View author publications
You can also search for this author in PubMed Google Scholar
Taro Shibuki
View author publications
You can also search for this author in PubMed Google Scholar
Kenta Nio
View author publications
You can also search for this author in PubMed Google Scholar
Yasushi Ide
View author publications
You can also search for this author in PubMed Google Scholar
Toshihiko Mizuta
View author publications
You can also search for this author in PubMed Google Scholar
Kenji Mitsugi
View author publications
You can also search for this author in PubMed Google Scholar
Norio Ureshino
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsuyoshi Shirakawa.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Cite this article

Otsuka, T., Shirakawa, T., Shimokawa, M. et al. Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study. Int J Clin Oncol 26, 951–953 (2021). https://doi.org/10.1007/s10147-021-01880-5

Download citation

Published: 03 March 2021
Issue Date: May 2021
DOI: https://doi.org/10.1007/s10147-021-01880-5

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Correction to: International Journal of Clinical Oncology https://doi.org/10.1007/s10147-021-01859-2

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's Note

About this article

Cite this article

Share this article

Search

Navigation